The evolving role of sirolimus in renal transplantation

16Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In summary, sirolimus is an exciting addition to our immunosuppressive armamentarium. There are encouraging early data suggesting that this drug may have significant advantages over existing agents, namely the promotion of tolerance, reduction in chronic allograft vasculopathy and avoidance of toxic effects of other immunosuppressive drugs. If further large clinical studies can confirm its safety and efficacy over a longer duration of follow-up this will no doubt promote its more widespread adoption.

Cite

CITATION STYLE

APA

Dupont, P., & Warrens, A. N. (2003, June 1). The evolving role of sirolimus in renal transplantation. QJM: An International Journal of Medicine. Oxford University Press. https://doi.org/10.1093/qjmed/hcg072

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free